von Moltke Lisa 4
4 · Zenas BioPharma, Inc. · Filed Apr 17, 2025
Insider Transaction Report
Form 4
von Moltke Lisa
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-04-15+400,000→ 400,000 totalExercise: $8.72Exp: 2035-04-14→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of common stock on March 17, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.